Vaxart, Inc. Skyrocketed
Fri, Apr 30, 2021 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) shot up at $10.78, representing a gain of 17%. On Thu, Apr 29, 2021, VXRT:NASDAQ touched a New 2-Week High of $9.21. The stock got featured on our News Catalysts scanner on Thu, Apr 29, 2021 at 08:33 AM in the 'BIOTECH' category. From Thu, Apr 15, 2021, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Feb 02, 2021 at $24.9 with a volume of 72M+.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 45.53%
- Image Sensing Systems, Inc. (ISNS:NASDAQ), 42.05%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 38.05%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 27.52%
- Farmmi, Inc. (FAMI:NASDAQ), 24.58%
- CryoLife, Inc. (CRY:NYSE), 24.22%
- SunLink Health Systems, Inc. (SSY:NYSEMKT), 23.21%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 17.91%
- Vaxart, Inc. (VXRT:NASDAQ), 17.05%
- Shineco, Inc. (TYHT:NASDAQ), 16.53%